Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.
about
Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.Argatroban in the management of heparin-induced thrombocytopenia.Comparison of bivalirudin dosing strategies using total, adjusted, and ideal body weights in obese patients with heparin-induced thrombocytopenia.Clinical experience with argatroban for heparin-induced thrombocytopenia in a large teaching hospital.
P2860
Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Argatroban anticoagulation in ...... arin-induced thrombocytopenia.
@ast
Argatroban anticoagulation in ...... arin-induced thrombocytopenia.
@en
type
label
Argatroban anticoagulation in ...... arin-induced thrombocytopenia.
@ast
Argatroban anticoagulation in ...... arin-induced thrombocytopenia.
@en
prefLabel
Argatroban anticoagulation in ...... arin-induced thrombocytopenia.
@ast
Argatroban anticoagulation in ...... arin-induced thrombocytopenia.
@en
P2093
P2860
P921
P356
P1476
Argatroban anticoagulation in ...... arin-induced thrombocytopenia.
@en
P2093
David A McCollum
G Mark Baillie
Lawrence Rice
Marcie J Hursting
P2860
P304
P356
10.1177/0091270007302951
P577
2007-05-24T00:00:00Z